what is unusual about glutathione's structure X-ray of glutathione S-transferase from the malarial parasite Plasmodium falciparum Glutathione S-transferase, C-terminal domain -

Anyone considering it should first consult a qualified healthcare professional, disclose all current medications, and understand that they would be using an experimental compound outside of any regulatory framework

Khavinson VK, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B

Topical formulations typically face fewer legal hurdles than systemic injectables, making them a safer entry point for non-medical users

A slower delivery rate reduces the peak concentration of GHK-Cu molecules at the injection point at any given moment, softening the pH disruption and the discomfort associated with it